MSCI ACWI exAU/CONSUMER GRTR US (NASDAQ:RWAYL – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 30th, there was short interest totaling 2,158 shares, a decline of 53.1% from the September 15th total of 4,601 shares. Based on an average daily volume of 3,777 shares, the short-interest ratio is presently 0.6 days.
MSCI ACWI exAU/CONSUMER GRTR US Price Performance
Shares of NASDAQ:RWAYL traded up $0.01 during trading on Wednesday, reaching $25.19. 2,256 shares of the company’s stock traded hands, compared to its average volume of 4,263. The company has a 50 day moving average of $25.17 and a 200-day moving average of $25.26. MSCI ACWI exAU/CONSUMER GRTR US has a 12 month low of $24.88 and a 12 month high of $25.73.
MSCI ACWI exAU/CONSUMER GRTR US Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 1st. Shareholders of record on Saturday, August 15th were given a $0.4688 dividend. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.88 annualized dividend and a yield of 7.4%.
MSCI ACWI exAU/CONSUMER GRTR US Company Profile
RWAYL represents a debt security issued by Runway Growth Finance Corporation, a business development company focused on providing customized debt financing to growth-stage companies. The company primarily serves venture capital- and private equity-backed businesses seeking capital to support expansion, acquisitions, working capital and other corporate purposes.
Runway Growth Finance typically invests through senior secured loans and other debt instruments, with a focus on companies operating in sectors such as technology, healthcare, consumer products and business services.
Further Reading
- Five stocks we like better than MSCI ACWI exAU/CONSUMER GRTR US
- Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen
- Birkenstock’s Strong Growth Creates a Buying Opportunity
- High Voltage Returns: Navitas Rewires AI Data Centers
- Quantum BioPharma’s Phase 2 Shows Where Biotech Value Actually Gets Built
Receive News & Ratings for MSCI ACWI exAU/CONSUMER GRTR US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI ACWI exAU/CONSUMER GRTR US and related companies with MarketBeat.com's FREE daily email newsletter.
